Potential marker for success of immunotherapy in the treatment of lung cancer: Lung cancer has the highest mortality rate of all cancers, and treatment options are extremely limited, especially for patients with oncogenic mutations in the KRAS gene. A great deal of hope was invested in the licensing of immune checkpoint inhibitors, but the reality […]
Lung cancer immunotherapy treatment








